UnitedHealthcare’s attempt to clarify its ill-advised advance notification program doesn’t change the fact that this replacement policy will delay care and limit access to life-saving colonoscopy and other endoscopic examinations that prevent cancer.
Continue Reading >>
Protecting Patient Access to Integrated GI Care in the Independent Setting
In an age when quality of care, cost-effectiveness and transparency are more important than ever, data demonstrates that high-quality, integrated care delivered in the independent medical practice setting is worthy of protection as an alternative to care that is often more costly when furnished in the hospital setting.
Statement on UnitedHealthcare’s Advance Notification Policy for Gastroenterology Services
Although UnitedHealthcare has decided not to implement its planned prior authorization policy in favor of an ill-defined advance notification program, we are concerned that this replacement policy creates a new pretext for future prior authorization requirements, which will delay care and limit access to life-saving colonoscopy and other endoscopic examinations that prevent cancer.
Continue Reading >>
Value of Colonoscopy Spanish Translation (Infographic)
Hay muchas opciones de detección, pero la colonoscopia es el estándar de oro. El cáncer colorrectal se previene mediante la extirpación de pólipos, que son crecimientos precancerosos. Y una colonoscopia de detección es la única prueba que DETECTA y ELIMINA los pólipos precancerosos.
Continue Reading >>
Colorectal Cancer: Am I at Risk? Spanish Translation (Infographic)
Es importante comprender que existen disparidades en las tasas de detección del cáncer colorrectal y que las tasas de mortalidad por la enfermedad son más altas entre algunos grupos étnicos que entre otros. Hay disparidades en las tasas de detección por muchas razones, incluido un menor acceso a la cobertura de atención médica, tasas más bajas de recomendación de un proveedor.
Continue Reading >>
DHPA Requests Safe Harbor for Copay Coupons for Drugs with no Lower-Cost Alternative
DHPA was among 18 provider and patient advocacy groups that signed onto a letter requesting that the Office of the Inspector General (OIG) issue new guidance indicating that manufacturer copay assistance to federal health program beneficiaries is a violation of the Anti-Kickback Statute when there is a less expensive and equally effective generic or interchangeable […]
Continue Reading >>
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 12
- Next Page »